Goldman Sachs Downgrades DaVita (DVA) to Neutral

February 15, 2013 6:57 AM EST Send to a Friend
Get Alerts DVA Hot Sheet
Price: $71.75 +0.41%

Rating Summary:
    9 Buy, 8 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 35 | Down: 23 | New: 13
Trade DVA Now!
Join SI Premium – FREE
Goldman Sachs downgraded DaVita (NYSE: DVA) from Buy to Neutral with a price target of $120 saying the stock is fairly valued and they see more upside elsewhere.

"While our outlook for core dialysis remains solid and we continue to see strong long-term growth potential in physician (HCP) and dialysis integrated care, we expect slower growth with less upward momentum to our/Street view over the next 12-24 months," the analyst comments.

For an analyst ratings summary and ratings history on DaVita click here. For more ratings news on DaVita click here.

Shares of DaVita closed at $119.21 yesterday.




You May Also Be Interested In


Related Categories

Analyst EPS View, Downgrades

Related Entities

Goldman Sachs

Add Your Comment